Skip to main content
logo
LigaChem Biosciences Inc. (KOSDAQ:141080)
South Korea flag South Korea · Delayed Price · Currency is KRW
85,200
-2,400 (-2.74%)
Sep 11, 2026, 3:30 PM KST

LigaChem Biosciences Balance Sheet

Millions KRW. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
84,08498,650128,91263,054117,965139,940
Short-Term Investments
299,772375,898365,03536,87151,98140,874
Cash & Short-Term Investments
383,856474,548493,94799,925169,946180,814
Cash Growth
-31.69%-3.93%394.32%-41.20%-6.01%90.81%
Accounts Receivable
10,67611,75613,71714,80912,78022,457
Other Receivables
4,63814,44614,7134,3476,40423,827
Receivables
15,31426,20328,54319,15619,18446,284
Inventory
98.23110.04212.47196.83198.82270.55
Prepaid Expenses
3,6492,5141,891785.42688.151,233
Other Current Assets
23,22118,06825,66814,5551,602349.11
Total Current Assets
426,139521,442550,262134,619191,619228,951
Property, Plant & Equipment
28,11727,71125,31325,42426,49224,432
Long-Term Investments
28,29041,48146,13017,34019,82522,631
Goodwill
16,08116,081----
Other Intangible Assets
89,09388,4008,4426,9017,8898,601
Long-Term Deferred Tax Assets
-113.37338.44981.16--
Other Long-Term Assets
6,2896,481107,8984,1436,6108,619
Total Assets
594,125701,815738,383189,502252,530293,233

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
6,3277,4287,6887,0957,2856,846
Accrued Expenses
7,38611,2518,95211,2683,764417.57
Short-Term Debt
---11,8472,700-
Current Portion of Long-Term Debt
----9,1472,700
Current Portion of Leases
988.351,059480.53268.56185.81158.2
Current Income Taxes Payable
--46.2---
Current Unearned Revenue
--4.65.512.4839.67
Other Current Liabilities
30,77341,354100,0116,5885,5086,857
Total Current Liabilities
45,47461,092117,18337,07228,60317,018
Long-Term Debt
-----9,147
Long-Term Leases
1,5991,691339.34528.37216.4263.35
Long-Term Unearned Revenue
3,6663,666----
Pension & Post-Retirement Benefits
7,1964,5894,4443,3652,6053,635
Long-Term Deferred Tax Liabilities
30,87431,078--1,1293,928
Other Long-Term Liabilities
64,35158,578418.28316.02378.15468.07
Total Liabilities
153,160160,695122,38541,28132,93234,459

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
18,51018,30518,30514,06012,75212,117
Additional Paid-In Capital
280,755258,787571,84097,52393,881349,792
Retained Earnings
102,022211,80636,33130,740105,383-109,586
Treasury Stock
-13,943-13,943-24,835-4,879--
Comprehensive Income & Other
12,81132,65914,35710,6266,5014,945
Total Common Equity
400,155507,614615,998148,071218,516257,268
Minority Interest
40,81133,506----
Shareholders' Equity
440,966541,120615,998148,221219,599258,775
Total Liabilities & Equity
594,125701,815738,383189,502252,530293,233

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
2,5882,749819.8712,64412,24912,269
Net Cash (Debt)
381,269471,798493,12887,281157,697168,545
Net Cash Growth
-31.79%-4.32%464.99%-44.65%-6.44%82.06%
Net Cash Per Share
10438.3812968.5514189.223072.855628.726986.35
Filing Date Shares Outstanding
36.8536.4436.2827.9825.524.23
Total Common Shares Outstanding
36.8536.4436.2827.9825.524.23
Working Capital
380,665460,350433,07997,547163,016211,933
Book Value Per Share
10859.4213930.3016978.065291.968568.2410615.60
Tangible Book Value
294,981403,133607,556141,169210,627248,667
Tangible Book Value Per Share
8005.2211063.0716745.385045.318258.9010260.69
Land
2,8152,8152,8152,8152,8152,815
Buildings
16,26516,20316,18816,13416,11916,104
Machinery
23,10621,42316,14813,82413,1359,060
Construction In Progress
830-177-184.65174